Skip to content

Evaluating a Brief Negotiational Intervention for Alcohol Use Among Injury Patients in Tanzania

Developing a Brief Negotiational Intervention for Alcohol Use Among Injury Patients in Tanzania

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02828267
Acronym
BNI
Enrollment
75
Registered
2016-07-11
Start date
2018-07-01
Completion date
2019-03-01
Last updated
2021-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use

Keywords

Tanzania, Alcohol Use, Brief Intervention

Brief summary

A brief negotiational interview (BNI), administered in an Emergency Department setting for both hazardous and harmful drinkers has been shown to cost-effectively reduce a patient's alcohol intake and re-injury rate up to 3 years post intervention. A BNI is a short (5-30 minute) counseling session administered by non-addiction specialists based on the concepts of the FRAMES model of motivational interviewing. Text based boosters have been proposed to prolong the impact of this intervention, either with a standardized or personalized content. The investigators will conduct a pilot study to test the feasibility of the study protocols, acceptance of the intervention, and patient enrollment and retention rates, as we prepare for a fully powered pragmatic randomized adaptive controlled trial of the intervention for patients seen at the Kilimanjaro Christian Medical Center (KCMC) Emergency Department.(ED)

Detailed description

Research Design: This will be a pilot randomized adaptive feasibility and acceptability trial. This will be a three stage trial where usual care, brief intervention and brief intervention with standard booster will be in the first stage. The second stage will drop the usual care arm. The third stage will keep an arm in stage two and a new arm, brief intervention with personalized booster. Since this is a feasibility trial, we will advance through potential adaptations, changing the enrollment procedures but not based on effectiveness testing as we are not powered for that endpoint. We have chosen brief intervention with standardized booster to continue in stage 3 to obtain more patient experience with the booster portion of the intervention. Participants and Recruitment: The investigators will prospectively enroll (n=75, 10 usual care, 20 BNI, 24 BNI + standard booster and 16 BNI + Personalized Booster) patients who present to the KCMC ED for care of acute injuries and meet inclusion and exclusion criteria. Trained research nurses will describe the intervention as a health assessment, and eligible interested participants will be enrolled, provide informed consent and a randomization packet chosen. The research nurses will then administer patient demographic, injury, alcohol use surveys and the intervention if appropriate all lasting less than 45 minutes. Follow-up Procedures: All groups will provide two phone numbers where participants can be reached in order to facilitate follow-up. All participants will be contacted at 6 weeks, 3 months and 6 months for follow-up survey administration. Follow up surveys are expected to be less than 20 minutes. All patients will be contacted by text message at the conclusion of the study to inform them about availability of the results of the study. Feasibility Trial Outcomes: Using the RE-AIM framework, we will define the reach (enrollment/ retention), the preliminary effectiveness (reduction in DrInC score), adoption including patient acceptance, implementation (intervention fidelity) and maintance (sustainability features). The investigators will conduct a feasibility assessment subjectively through self-assessments as well as objectively through Event Analyses, understanding causes of deviations from protocol, intervention evaluations and questionnaires. Study Procedures: To evaluate the study procedures, the investigators will evaluate any protocol deviation events, and compare length of survey times. The investigators will also perform assessments of intervention fidelity through reviewing recorded observations of BNI administration using the BNI Assessment Scale. Reach: Enrollment and Retention The primary outcome measure will be recruitment and retention rates, anticipated at 30% and 60%, respectively. Secondarily, the investigators will qualitatively assess the inclusion and exclusion criteria, reasons for non-enrollment or non-retention, to the extent possible. Finally, the investigators will administer follow-up questions about compensation procedures in order to improve enrollment or retention. Effectiveness: We will evaluate the DrInC (Drinker Inventory of Consequences), AUDIT (Alcohol Use Disorder Identification Test) scores, number of drinking days and number of binge drinking days. We are not powered to determine effectiveness, so this is a preliminary effectiveness only. Adoption: We will evaluate patient acceptance and perception of effectiveness for the adoption of this intervention. The investigators will assess acceptability of participation in the trial and intervention through questions administered after the final follow-up time point for both the research team as well as participants. This will include assessment about the length of surveys, and method and quantity of follow-up. Implementation: We will evaluate implementation preparedness with an evaluation of the time burden of the BNI, and intervention fidelity both for the BNI, and SMS boosters but also trial protocols. Maintenance: We will determine sustainability through the burden of administration of the BNI as perceived by research nurses administering the intervention, the attitudes towards effectiveness of interventionists and participants, the cost and feasibility of this type of this adaptive clinical trial in this setting.

Interventions

BEHAVIORALBrief Negotiational Intervention

This is a 5-10 minute conversation using the principles of motivational interviewing between the healthcare practioner and the patient to motivate the patient to identify at risk alcohol use and through self-empowerment create a plan to decrease alcohol use.

This SMS based intervention will be a text to the participant once weekly including motivational statements to try to have patients reduce their alcohol use.

This SMS based intervention will be a text to the participant once weekly including motivational statements to try to have patients reduce their alcohol use. Information in this text will be personalized based on the participants specific reasons for reducing their alcohol use rather than a standard text content.

Sponsors

Kilimanjaro Christian Medical Centre, Tanzania
CollaboratorOTHER
Fogarty International Center of the National Institute of Health
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigators and outcome assessors are not privy as to which arm patients were randomized to. Participants obviously are aware if they participate in a discussion and receive texts.

Intervention model description

This is an feasiblity trial of a three stage adaptive clinical trial. Stage one has three arms (UC, BNI, BNI+ Standard booster). Stage two drops usual care arm. Stage three continues the strongest arm for phase two (which was choosen as BNI + Standard Booster for this feasiblity trial not powered to determine efficacy) and a new arm BNI + Personalized Booster.

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* \>18 years of age * be clinically sober at the time of enrollment * have capacity to give informed consent * converse in the local language Swahili or in English * have either: * reported ingesting alcohol in the 6 hours prior to injury, * have a positive breathalyzer test, or * have an Alcohol Use Disorder Identification Test with a score of ≥8.

Exclusion criteria

* \<18 years of age * being clinically intoxicated * being injured so severely that participants do not have the capacity to give informed consent * not able to converse in Swahili or English

Design outcomes

Primary

MeasureTime frameDescription
Enrollment Rateover the course of the study, approximately 8 monthsThe average number of participants enrolled per week over the course of the study.
Drinker Inventory of Consequences (DrInC) Score6 weeks, 3 months, 6 monthsThe DrInC is a self-administered 50-item questionnaire designed to measure adverse consequences of alcohol abuse in five areas: Interpersonal, Physical, Social, Impulsive, and Intrapersonal. Scales are combined to assess total adverse consequences, with higher scores indicating more adverse consequences. This is a mean and standard deviation of the number of consequences suffered by participants since enrollment. The total DrInC score is reported where is 0 (no consequences) to 50 (every consequence experienced).

Secondary

MeasureTime frameDescription
Retention Rates6 weeks, 3 months, 6 monthsReported as the number of participants who complete each follow up visit.
Alcohol Use Disorder Identification Test (AUDIT) Score6 weeks, 3 months, 6 monthsThe AUDIT is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. The scale ranges from 0 to 40; a score of 8 or more is considered to indicate hazardous or harmful alcohol use. Presented as the AUDIT mean score over the month prior to visit.

Countries

Tanzania

Participant flow

Participants by arm

ArmCount
Usual Care
In the Usual Care arm, patients will have standard discharge information and instructions without any further health or wellness instruction
10
Brief Negotiational Interview (BNI)
In the BNI arm, patients will receive a 5-10 minute brief negotiational intervention about their alcohol use as well as the standard discharge information and instructions. Brief Negotiational Intervention: This is a 5-10 minute conversation using the principles of motivational interviewing between the healthcare practioner and the patient to motivate the patient to identify at risk alcohol use and through self-empowerment create a plan to decrease alcohol use.
21
BNI Plus Standard Booster
In the BNI plus standard booster arm, patients will receive a 5-10 minute brief negotiational intervention about their alcohol use as well as the standard discharge information and instructions. Then after discharge patients will receive a test focused on reducing alcohol use to a SMS capable cell phone weekly for a total of 6 months of follow up. The messages will be standard messages for all those in this arm. Brief Negotiational Intervention: This is a 5-10 minute conversation using the principles of motivational interviewing between the healthcare practioner and the patient to motivate the patient to identify at risk alcohol use and through self-empowerment create a plan to decrease alcohol use. Standard Booster: This SMS based intervention will be a text to the participant once weekly including motivational statements to try to have patients reduce their alcohol use.
24
BNI Plus Personalized Booster
In the BNI plus personalized booster arm, patients will receive a 5-10 minute brief negotiational intervention about their alcohol use as well as the standard discharge information and instructions. Then after discharge patients will receive a test focused on reducing alcohol use to a SMS capable cell phone weekly for a total of 6 months of follow up. In the personalized arm, the text sent will be personalized based on information obtained about the patient's reasons for reducing their drinking found in the BNI. Brief Negotiational Intervention: This is a 5-10 minute conversation using the principles of motivational interviewing between the healthcare practioner and the patient to motivate the patient to identify at risk alcohol use and through self-empowerment create a plan to decrease alcohol use. Personalized Booster: This SMS based intervention will be a text to the participant once weekly including motivational statements to try to have patients reduce their alcohol use. Information in this text will be personalized based on the participants specific reasons for reducing their alcohol use rather than a standard text content.
20
Total75

Baseline characteristics

CharacteristicBrief Negotiational Interview (BNI)Usual CareBNI Plus Standard BoosterBNI Plus Personalized BoosterTotal
Age, Continuous40.6 years
STANDARD_DEVIATION 13.8
36.7 years
STANDARD_DEVIATION 12.8
36.6 years
STANDARD_DEVIATION 14.5
31.4 years
STANDARD_DEVIATION 11.8
36.3 years
STANDARD_DEVIATION 13.5
Alcohol Use Disorder Identification Test (AUDIT) Score13.9 score on a scale
STANDARD_DEVIATION 6.4
9.7 score on a scale
STANDARD_DEVIATION 3.8
12.1 score on a scale
STANDARD_DEVIATION 6.5
12.9 score on a scale
STANDARD_DEVIATION 7.2
12.5 score on a scale
STANDARD_DEVIATION 6.4
Drinker Inventory of Consequences (DrInC)20.3 score on a scale
STANDARD_DEVIATION 7.3
14.7 score on a scale
STANDARD_DEVIATION 8
16.0 score on a scale
STANDARD_DEVIATION 10.3
15.0 score on a scale
STANDARD_DEVIATION 8.7
16.8 score on a scale
STANDARD_DEVIATION 8.9
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
21 Participants10 Participants24 Participants20 Participants75 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
Tanzania
21 Participants10 Participants24 Participants20 Participants75 Participants
Sex: Female, Male
Female
2 Participants0 Participants1 Participants0 Participants3 Participants
Sex: Female, Male
Male
19 Participants10 Participants23 Participants20 Participants72 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 210 / 240 / 20
other
Total, other adverse events
0 / 100 / 210 / 240 / 20
serious
Total, serious adverse events
0 / 100 / 210 / 240 / 20

Outcome results

Primary

Drinker Inventory of Consequences (DrInC) Score

The DrInC is a self-administered 50-item questionnaire designed to measure adverse consequences of alcohol abuse in five areas: Interpersonal, Physical, Social, Impulsive, and Intrapersonal. Scales are combined to assess total adverse consequences, with higher scores indicating more adverse consequences. This is a mean and standard deviation of the number of consequences suffered by participants since enrollment. The total DrInC score is reported where is 0 (no consequences) to 50 (every consequence experienced).

Time frame: 6 weeks, 3 months, 6 months

Population: Participants who completed the specific follow up time point were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Total Enrolled Patient SampleDrinker Inventory of Consequences (DrInC) Score6 weeks0.2 score on the total scaleStandard Deviation 0.7
Total Enrolled Patient SampleDrinker Inventory of Consequences (DrInC) Score6 months1.3 score on the total scaleStandard Deviation 3.5
Total Enrolled Patient SampleDrinker Inventory of Consequences (DrInC) Score3 months0.2 score on the total scaleStandard Deviation 0.6
BNI OnlyDrinker Inventory of Consequences (DrInC) Score6 weeks0.9 score on the total scaleStandard Deviation 1.8
BNI OnlyDrinker Inventory of Consequences (DrInC) Score6 months1.2 score on the total scaleStandard Deviation 3.2
BNI OnlyDrinker Inventory of Consequences (DrInC) Score3 months0.4 score on the total scaleStandard Deviation 1.1
BNI Plus Standard BoosterDrinker Inventory of Consequences (DrInC) Score3 months2.4 score on the total scaleStandard Deviation 8.5
BNI Plus Standard BoosterDrinker Inventory of Consequences (DrInC) Score6 weeks1.9 score on the total scaleStandard Deviation 7.8
BNI Plus Standard BoosterDrinker Inventory of Consequences (DrInC) Score6 months1.0 score on the total scaleStandard Deviation 3.1
BNI Plus Personalized BoosterDrinker Inventory of Consequences (DrInC) Score6 weeks0.3 score on the total scaleStandard Deviation 0.9
BNI Plus Personalized BoosterDrinker Inventory of Consequences (DrInC) Score6 months0.7 score on the total scaleStandard Deviation 1.5
BNI Plus Personalized BoosterDrinker Inventory of Consequences (DrInC) Score3 months0.7 score on the total scaleStandard Deviation 1.2
Primary

Enrollment Rate

The average number of participants enrolled per week over the course of the study.

Time frame: over the course of the study, approximately 8 months

ArmMeasureValue (MEAN)
Total Enrolled Patient SampleEnrollment Rate6.25 average participants per week
Secondary

Alcohol Use Disorder Identification Test (AUDIT) Score

The AUDIT is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. The scale ranges from 0 to 40; a score of 8 or more is considered to indicate hazardous or harmful alcohol use. Presented as the AUDIT mean score over the month prior to visit.

Time frame: 6 weeks, 3 months, 6 months

Population: Only those participants who were retained on follow up were analyzed.

ArmMeasureGroupValue (MEAN)Dispersion
Total Enrolled Patient SampleAlcohol Use Disorder Identification Test (AUDIT) Score6 weeks0.33 score on a scaleStandard Deviation 1
Total Enrolled Patient SampleAlcohol Use Disorder Identification Test (AUDIT) Score6 months4.4 score on a scaleStandard Deviation 5.3
Total Enrolled Patient SampleAlcohol Use Disorder Identification Test (AUDIT) Score3 months0.7 score on a scaleStandard Deviation 0.9
BNI OnlyAlcohol Use Disorder Identification Test (AUDIT) Score6 weeks1.5 score on a scaleStandard Deviation 2.5
BNI OnlyAlcohol Use Disorder Identification Test (AUDIT) Score6 months4.0 score on a scaleStandard Deviation 4.1
BNI OnlyAlcohol Use Disorder Identification Test (AUDIT) Score3 months1.9 score on a scaleStandard Deviation 1.3
BNI Plus Standard BoosterAlcohol Use Disorder Identification Test (AUDIT) Score3 months2.9 score on a scaleStandard Deviation 5
BNI Plus Standard BoosterAlcohol Use Disorder Identification Test (AUDIT) Score6 weeks1.9 score on a scaleStandard Deviation 5.3
BNI Plus Standard BoosterAlcohol Use Disorder Identification Test (AUDIT) Score6 months3.3 score on a scaleStandard Deviation 2.3
BNI Plus Personalized BoosterAlcohol Use Disorder Identification Test (AUDIT) Score6 weeks1.2 score on a scaleStandard Deviation 1.4
BNI Plus Personalized BoosterAlcohol Use Disorder Identification Test (AUDIT) Score6 months4.9 score on a scaleStandard Deviation 2.6
BNI Plus Personalized BoosterAlcohol Use Disorder Identification Test (AUDIT) Score3 months2.7 score on a scaleStandard Deviation 1.4
Secondary

Retention Rates

Reported as the number of participants who complete each follow up visit.

Time frame: 6 weeks, 3 months, 6 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Total Enrolled Patient SampleRetention Rates6 weeks9 Participants
Total Enrolled Patient SampleRetention Rates6 months10 Participants
Total Enrolled Patient SampleRetention Rates3 months10 Participants
BNI OnlyRetention Rates3 months15 Participants
BNI OnlyRetention Rates6 weeks15 Participants
BNI OnlyRetention Rates6 months17 Participants
BNI Plus Standard BoosterRetention Rates3 months20 Participants
BNI Plus Standard BoosterRetention Rates6 weeks17 Participants
BNI Plus Standard BoosterRetention Rates6 months19 Participants
BNI Plus Personalized BoosterRetention Rates6 weeks19 Participants
BNI Plus Personalized BoosterRetention Rates6 months17 Participants
BNI Plus Personalized BoosterRetention Rates3 months17 Participants
All Trial ParticipantsRetention Rates3 months62 Participants
All Trial ParticipantsRetention Rates6 weeks60 Participants
All Trial ParticipantsRetention Rates6 months63 Participants

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026